Athira Pharma
ATHA
ATHA
65 hedge funds and large institutions have $58.8M invested in Athira Pharma in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
48% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 23
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
Holders
65
Holding in Top 10
–
Calls
$200K
Puts
$308K
Top Buyers
| 1 | +$3.43M | |
| 2 | +$530K | |
| 3 | +$296K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$126K |
| 5 |
FA
Forefront Analytics
West Conshohocken,
Pennsylvania
|
+$68.8K |
Top Sellers
| 1 | -$614K | |
| 2 | -$402K | |
| 3 | -$362K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$354K |
| 5 |
Millennium Management
New York
|
-$347K |